99 related articles for article (PubMed ID: 4395478)
1. Catecholamines in hypertension.
Sjoerdsma A
Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):118-20. PubMed ID: 4395478
[No Abstract] [Full Text] [Related]
2. [Sympathetic nervous system and catecholamines in hypertension].
Jäättelä A
Duodecim; 1974; 90(9):676-84. PubMed ID: 4608898
[No Abstract] [Full Text] [Related]
3. Pheochromocytoma resistant to alpha-adrenergic blockade.
Hauptman JB; Modlinger RS; Ertel NH
Arch Intern Med; 1983 Dec; 143(12):2321-3. PubMed ID: 6139989
[TBL] [Abstract][Full Text] [Related]
4. Metyrosine and pheochromocytoma.
Steinsapir J; Carr AA; Prisant LM; Bransome ED
Arch Intern Med; 1997 Apr; 157(8):901-6. PubMed ID: 9129550
[TBL] [Abstract][Full Text] [Related]
5. Catecholamines and essential hypertension.
Robertson D; Nies AS
J S C Med Assoc; 1977 Dec; 73(12):519-22. PubMed ID: 338988
[No Abstract] [Full Text] [Related]
6. [Biochemical measurement of the function of the adrenal medulla and sympathetic system in the clinic].
Jéquier E
Schweiz Med Wochenschr; 1970 Mar; 100(12):532-6. PubMed ID: 4906883
[No Abstract] [Full Text] [Related]
7. Pheochromocytoma.
Med Lett Drugs Ther; 1967 May; 9(9):34-6. PubMed ID: 6035362
[No Abstract] [Full Text] [Related]
8. Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings.
Kopin IJ
Pharmacol Rev; 1966 Mar; 18(1):513-23. PubMed ID: 5904165
[No Abstract] [Full Text] [Related]
9. Pheochromocytoma: advances in diagnosis and treatment.
Pertsemlidis D; Gitlow SE; Kark AE
Surg Annu; 1972; 4():345-57. PubMed ID: 4589383
[No Abstract] [Full Text] [Related]
10. Current evaluation and management of pheochromocytoma.
Harrison TS; Bartlett JD; Seaton JF
Ann Surg; 1968 Oct; 168(4):701-13. PubMed ID: 5693023
[No Abstract] [Full Text] [Related]
11. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
Tcherdakoff P; Ménard J; Bedrossian J; Vaysse J; Alexandre JM; Milliez P
Sem Hop; 1972 May; 48(25):1779-87. PubMed ID: 4405188
[No Abstract] [Full Text] [Related]
12. [Effect of ganglionic block on hematic and urinary dynamics of catecholamines in arterial hypertension].
Consolo F; Scaffidi L; Arrigo F
Cuore Circ; 1970 Jun; 54(3):99-113. PubMed ID: 4394251
[No Abstract] [Full Text] [Related]
13. Histochemical and functional relationships of catecholamines in adrenergic nerve endings. I. Participation of granular vesicles.
Van Orden LS; Bloom FE; Barnett RJ; Giarman NJ
J Pharmacol Exp Ther; 1966 Nov; 154(2):185-99. PubMed ID: 5950955
[No Abstract] [Full Text] [Related]
14. Diagnosis and treatment of pheochromocytoma.
Wolf RL; Mendlowitz M; Fruchter A
Mt Sinai J Med; 1970; 37(4):549-67. PubMed ID: 4393751
[No Abstract] [Full Text] [Related]
15. Conjugation of catecholamines, a variable to be accounted for in human hypertension.
Kuchel O; Buu NT; Hamet P; Larochelle P; Genest J
Prog Biochem Pharmacol; 1980; 17():66-74. PubMed ID: 6937881
[TBL] [Abstract][Full Text] [Related]
16. [The influencing of catecholamine liberation in nerve endings].
Schönhöfer P
Schweiz Rundsch Med Prax; 1971 Jun; 60(26):867-70. PubMed ID: 5092314
[No Abstract] [Full Text] [Related]
17. Acute pheochromocytoma.
Egdahl RH; Chobanian AV
Surg Clin North Am; 1966 Jun; 46(3):645-52. PubMed ID: 5931812
[No Abstract] [Full Text] [Related]
18. Further evaluation of the tyramine test for pheochromocytoma.
Engelman K; Horwitz D; Ambrose IM; Sjoerdsma A
N Engl J Med; 1968 Mar; 278(13):705-9. PubMed ID: 5638691
[No Abstract] [Full Text] [Related]
19. Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension.
Westfall TC; Meldrum MJ
Annu Rev Pharmacol Toxicol; 1985; 25():621-41. PubMed ID: 3890711
[No Abstract] [Full Text] [Related]
20. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
Thoenen H; Huerlimann A; Haefely W
J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
[No Abstract] [Full Text] [Related]
[Next] [New Search]
